Search Results
10
Everything
Search Filters
Organization
NeuroOne Medical Technologies Corporation
NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace - Update
March 18, 2025 13:12 ET
|
NeuroOne Medical Technologies Corporation
EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace
March 18, 2025 09:00 ET
|
NeuroOne Medical Technologies Corporation
EDEN PRAIRIE, Minn., March 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
March 11, 2025 09:00 ET
|
NeuroOne Medical Technologies Corporation
Submission for New Intended Use That Leverages Company’s Patented OneRF® Technology Platform Expected in May 2025 EDEN PRAIRIE, Minn., March 11, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical...
NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference
March 05, 2025 09:00 ET
|
NeuroOne Medical Technologies Corporation
EDEN PRAIRIE, Minn., March 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update
February 12, 2025 08:00 ET
|
NeuroOne Medical Technologies Corporation
Total revenue of $6.3M Includes $3.3 Million of Product Revenue in Addition to a One-Time Upfront Payment of $3.0 Million in License Revenue from Zimmer Biomet EDEN PRAIRIE, Minn., Feb. 12, 2025 ...
NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time
February 05, 2025 11:00 ET
|
NeuroOne Medical Technologies Corporation
EDEN PRAIRIE, Minn., Feb. 05, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® Regains Compliance with Nasdaq Listing Requirements
February 04, 2025 10:56 ET
|
NeuroOne Medical Technologies Corporation
EDEN PRAIRIE, Minn., Feb. 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million
January 10, 2025 08:30 ET
|
NeuroOne Medical Technologies Corporation
First Quarter Fiscal 2025 Revenue Includes a One-Time Upfront Payment of $3.0 Million in Collaboration Revenue from Zimmer Biomet and $3.2M in Product Revenue Management to Host Virtual Investor...
NeuroOne® Announces Change of Virtual Investor Webinar to Friday, January 10, 2024
January 06, 2025 08:30 ET
|
NeuroOne Medical Technologies Corp
Company to Provide Overview of Business Model and Expected Revenue Acceleration in Fiscal Year 2025 EDEN PRAIRIE, Minn., Jan. 06, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation...
NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST
January 03, 2025 08:30 ET
|
NeuroOne Medical Technologies Corp
Company to Provide Overview of Business Model and Expected Revenue Acceleration in Fiscal Year 2025 EDEN PRAIRIE, Minn., Jan. 03, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation...